Business Context and Reporting Period
Company: ASTROTECH Corp
Filing Type: Form 8-K (Current Report)
Date of Report: August 6, 2013
Reporting Period: The filing reports on a specific corporate governance event occurring on August 6, 2013, regarding the modification of security holder rights.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a legal disclosure regarding the extension of a poison pill provision (Rights Agreement) and does not report operational or financial performance metrics.
Material Changes
Extension of Rights Agreement: The Company entered into Amendment Four to its Rights Agreement with American Stock Transfer & Trust Company, LLC. This amendment extends the expiration date of the preferred share purchase rights (Rights) from August 10, 2013, to August 10, 2014. This follows a series of annual extensions since the Rights were originally declared in 2009.
Guidance, Outlook, and Risks
Management Commentary: The filing provides no forward-looking guidance, outlook, or management commentary regarding business strategy or financial performance.
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard maintenance of the Rights Agreement, which serves as a defensive mechanism against unsolicited takeover attempts. The text notes that the description of the Amendment is qualified by reference to the full agreement attached as Exhibit 4.1.
Key Facts for Investor Verification
- The Rights Agreement expiration date has been extended by one year to August 10, 2014.
- The Rights were originally declared on July 29, 2009, and have been extended annually since 2010.
- The Rights Agent remains American Stock Transfer & Trust Company, LLC.
- Investors should review Exhibit 4.1 (Amendment Four to Rights Agreement) for the complete legal terms of the extension.
- This filing contains no financial data; investors should refer to the most recent 10-K or 10-Q for financial performance.